Cargando…

Diffusion of new antiretroviral drugs in CSF

Detalles Bibliográficos
Autor principal:	Aweeka, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316092/ http://dx.doi.org/10.1186/1742-4690-7-S1-I8

Ejemplares similares

New antiretrovirals
por: Gulick, Roy
Publicado: (2012)

Resistance to new antiretrovirals (ETV, anti-integrases, entry inhibitors)
por: Ceccherini-Silberstein, Francesca
Publicado: (2010)

Evidence-based TDM for antiretroviral drugs
por: Solas, Caroline
Publicado: (2010)

Use of new resistance markers to predict virologic response to antiretrovirals
por: Wainberg, Mark A, et al.
Publicado: (2010)

Antiretroviral generics
por: Andrieu, Véronique
Publicado: (2012)

Managing antiretrovirals in co-infected patients in 2012
por: Rockstroh, Jürgen
Publicado: (2012)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

New anti HCV drugs in the pipeline
por: Bourlière, Marc
Publicado: (2010)

New drug interactions in HIV and HCV
por: Back, David
Publicado: (2012)

Use of new technologies to detect and understand HIV drug resistance
por: Kozal, Michael J
Publicado: (2010)

Drug-drug interactions: it is not only CYP450's which matter
por: Back, David J
Publicado: (2010)

Analgesic drug development: time to break the mould
por: Woolf, Clifford
Publicado: (2013)

Transporters used by parasites as drug targets: tempting but underexploited
por: Staines, Henry
Publicado: (2010)

Rehabilitation from symptomatic drugs overuse: yes, no, may be
por: Tassorelli, Cristina, et al.
Publicado: (2015)

Type 1 diabetes - an auto-inflammatory disease: a new concept, new therapeutical strategies
por: Limbert, Catarina
Publicado: (2012)

What is new in the treatment of eosinophilic eosophagitis?
por: Assa'ad, Amal
Publicado: (2011)

New therapeutic perspectives – amyloid removal
por: Pepys, Mark
Publicado: (2015)

New medicines to improve control and contribute to the eradication of malaria
por: Wells, Timothy NC
Publicado: (2010)

Retroviral restriction factors: new mechanisms of innate immunity
por: Wolf, Daniel, et al.
Publicado: (2009)

Finding new immune regulatory genes by ENU mutagenesis
por: Enders, Anselm, et al.
Publicado: (2012)

New tools to diagnose and follow FAC patients: biomarkers
por: Merlini, Giampaolo
Publicado: (2015)

New perspectives on immunological pathways underlying peanut-induced anaphylaxis
por: Jordana, Manel
Publicado: (2011)

PReS13-SPK-1240: New aspects on APS pathogenesis
por: Meroni, PL
Publicado: (2013)

Impact of a new European regulations on functional food market – an overview
por: Lovik, Martinus
Publicado: (2011)

PReS13-SPK-1034: looking for new monogenic forms of lupus
por: Crow, Y
Publicado: (2013)

Food allergen protein families and their structural characteristics: new data from Europrevail
por: Hoffmann-Sommergruber, Karin
Publicado: (2011)

PReS13-SPK-1253: Challenges in nursing care with the new biologics for JIA
por: Livermore, P
Publicado: (2013)

PReS13-SPK-1137: New developments in our care & understanding of JIA
por: Beresford, MW
Publicado: (2013)

PReS13-SPK-1478: New developments in our care & understanding of JIA
por: Wedderburn, L
Publicado: (2013)

New ARV drugs
por: Gulick, Roy
Publicado: (2014)

Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome
por: Van den Steen, Philippe E, et al.
Publicado: (2010)

PReS13-SPK-1587: New biologic targets for the future and basic science behind them
por: Prakken, B
Publicado: (2013)

A novel drug for uncomplicated malaria: targeted high throughput screening (HTS) against the type II NADH:ubiquinone oxidoreductase (PfNdh2) of Plasmodium falciparum
por: Ward, Steve A, et al.
Publicado: (2010)

PReS13-SPK-1408: New EU scientific guidelines for JIA, SLE and GIOP from the European Medicines Agency
por: Vesely, R
Publicado: (2013)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

Cortical modulation of thalamic function during cortical spreading depression- Unraveling a new central mechanism involved in migraine aura"
por: Andreou, Anna P, et al.
Publicado: (2013)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

S81. Proffered paper: A new PD1-CD28 chimeric receptor overcomes PD-1-mediated immunosuppression in adoptive T cell therapy
por: Grassmann, S, et al.
Publicado: (2014)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_274o031e0ni56gcedshnfl3pb6